Cargando…

High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda

BACKGROUND: Neurocysticercosis (NCC), the central nervous system infection by Taenia solium larvae, is a preventable and treatable cause of epilepsy. In Sub-Saharan Africa, the role of NCC in epilepsy differs geographically and, overall, is poorly defined. We aimed at contributing specific, first da...

Descripción completa

Detalles Bibliográficos
Autores principales: Rottbeck, Ruth, Nshimiyimana, Jules Fidèle, Tugirimana, Pierrot, Düll, Uta E., Sattler, Janko, Hategekimana, Jean-Claudien, Hitayezu, Janvier, Bruckmaier, Irmengard, Borchert, Matthias, Gahutu, Jean Bosco, Dieckmann, Sebastian, Harms, Gundel, Mockenhaupt, Frank P., Ignatius, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828157/
https://www.ncbi.nlm.nih.gov/pubmed/24244783
http://dx.doi.org/10.1371/journal.pntd.0002558
_version_ 1782291189892907008
author Rottbeck, Ruth
Nshimiyimana, Jules Fidèle
Tugirimana, Pierrot
Düll, Uta E.
Sattler, Janko
Hategekimana, Jean-Claudien
Hitayezu, Janvier
Bruckmaier, Irmengard
Borchert, Matthias
Gahutu, Jean Bosco
Dieckmann, Sebastian
Harms, Gundel
Mockenhaupt, Frank P.
Ignatius, Ralf
author_facet Rottbeck, Ruth
Nshimiyimana, Jules Fidèle
Tugirimana, Pierrot
Düll, Uta E.
Sattler, Janko
Hategekimana, Jean-Claudien
Hitayezu, Janvier
Bruckmaier, Irmengard
Borchert, Matthias
Gahutu, Jean Bosco
Dieckmann, Sebastian
Harms, Gundel
Mockenhaupt, Frank P.
Ignatius, Ralf
author_sort Rottbeck, Ruth
collection PubMed
description BACKGROUND: Neurocysticercosis (NCC), the central nervous system infection by Taenia solium larvae, is a preventable and treatable cause of epilepsy. In Sub-Saharan Africa, the role of NCC in epilepsy differs geographically and, overall, is poorly defined. We aimed at contributing specific, first data for Rwanda, assessing factors associated with NCC, and evaluating a real-time PCR assay to diagnose NCC in cerebrospinal fluid (CSF). METHODOLOGY/PRINCIPAL FINDINGS: At three healthcare facilities in southern Rwanda, 215 people with epilepsy (PWE) and 51 controls were clinically examined, interviewed, and tested by immunoblot for cysticerci-specific serum antibodies. Additionally, CSF samples from PWE were tested for anticysticercal antibodies by ELISA and for parasite DNA by PCR. Cranial computer tomography (CT) scans were available for 12.1% of PWE with additional symptoms suggestive of NCC. The Del Brutto criteria were applied for NCC diagnosis. Cysticerci-specific serum antibodies were found in 21.8% of PWE and 4% of controls (odds ratio (OR), 6.69; 95% confidence interval (95%CI), 1.6–58.7). Seropositivity was associated with age and lack of safe drinking water. Fifty (23.3%) PWE were considered NCC cases (definitive, based on CT scans, 7.4%; probable, mainly based on positive immunoblots, 15.8%). In CSF samples from NCC cases, anticysticercal antibodies were detected in 10% (definitive cases, 25%) and parasite DNA in 16% (definitive cases, 44%). Immunoblot-positive PWE were older (medians, 30 vs. 22 years), more frequently had late-onset epilepsy (at age >25 years; 43.5% vs. 8.5%; OR, 8.30; 95%CI, 3.5–20.0), and suffered from significantly fewer episodes of seizures in the preceding six months than immunoblot-negative PWE. CONCLUSIONS/SIGNIFICANCE: NCC is present and contributes to epilepsy in southern Rwanda. Systematic investigations into porcine and human cysticercosis as well as health education and hygiene measures for T. solium control are needed. PCR might provide an additional, highly specific tool in NCC diagnosis.
format Online
Article
Text
id pubmed-3828157
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38281572013-11-16 High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda Rottbeck, Ruth Nshimiyimana, Jules Fidèle Tugirimana, Pierrot Düll, Uta E. Sattler, Janko Hategekimana, Jean-Claudien Hitayezu, Janvier Bruckmaier, Irmengard Borchert, Matthias Gahutu, Jean Bosco Dieckmann, Sebastian Harms, Gundel Mockenhaupt, Frank P. Ignatius, Ralf PLoS Negl Trop Dis Research Article BACKGROUND: Neurocysticercosis (NCC), the central nervous system infection by Taenia solium larvae, is a preventable and treatable cause of epilepsy. In Sub-Saharan Africa, the role of NCC in epilepsy differs geographically and, overall, is poorly defined. We aimed at contributing specific, first data for Rwanda, assessing factors associated with NCC, and evaluating a real-time PCR assay to diagnose NCC in cerebrospinal fluid (CSF). METHODOLOGY/PRINCIPAL FINDINGS: At three healthcare facilities in southern Rwanda, 215 people with epilepsy (PWE) and 51 controls were clinically examined, interviewed, and tested by immunoblot for cysticerci-specific serum antibodies. Additionally, CSF samples from PWE were tested for anticysticercal antibodies by ELISA and for parasite DNA by PCR. Cranial computer tomography (CT) scans were available for 12.1% of PWE with additional symptoms suggestive of NCC. The Del Brutto criteria were applied for NCC diagnosis. Cysticerci-specific serum antibodies were found in 21.8% of PWE and 4% of controls (odds ratio (OR), 6.69; 95% confidence interval (95%CI), 1.6–58.7). Seropositivity was associated with age and lack of safe drinking water. Fifty (23.3%) PWE were considered NCC cases (definitive, based on CT scans, 7.4%; probable, mainly based on positive immunoblots, 15.8%). In CSF samples from NCC cases, anticysticercal antibodies were detected in 10% (definitive cases, 25%) and parasite DNA in 16% (definitive cases, 44%). Immunoblot-positive PWE were older (medians, 30 vs. 22 years), more frequently had late-onset epilepsy (at age >25 years; 43.5% vs. 8.5%; OR, 8.30; 95%CI, 3.5–20.0), and suffered from significantly fewer episodes of seizures in the preceding six months than immunoblot-negative PWE. CONCLUSIONS/SIGNIFICANCE: NCC is present and contributes to epilepsy in southern Rwanda. Systematic investigations into porcine and human cysticercosis as well as health education and hygiene measures for T. solium control are needed. PCR might provide an additional, highly specific tool in NCC diagnosis. Public Library of Science 2013-11-14 /pmc/articles/PMC3828157/ /pubmed/24244783 http://dx.doi.org/10.1371/journal.pntd.0002558 Text en © 2013 Rottbeck et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Rottbeck, Ruth
Nshimiyimana, Jules Fidèle
Tugirimana, Pierrot
Düll, Uta E.
Sattler, Janko
Hategekimana, Jean-Claudien
Hitayezu, Janvier
Bruckmaier, Irmengard
Borchert, Matthias
Gahutu, Jean Bosco
Dieckmann, Sebastian
Harms, Gundel
Mockenhaupt, Frank P.
Ignatius, Ralf
High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda
title High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda
title_full High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda
title_fullStr High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda
title_full_unstemmed High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda
title_short High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda
title_sort high prevalence of cysticercosis in people with epilepsy in southern rwanda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828157/
https://www.ncbi.nlm.nih.gov/pubmed/24244783
http://dx.doi.org/10.1371/journal.pntd.0002558
work_keys_str_mv AT rottbeckruth highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT nshimiyimanajulesfidele highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT tugirimanapierrot highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT dullutae highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT sattlerjanko highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT hategekimanajeanclaudien highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT hitayezujanvier highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT bruckmaierirmengard highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT borchertmatthias highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT gahutujeanbosco highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT dieckmannsebastian highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT harmsgundel highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT mockenhauptfrankp highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda
AT ignatiusralf highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda